2 June 2020 (Tuesday) - Transfusion Evidence Update

The nice people at the Transfusion Evidence Alert sent their update today. It is rather weighted in favour of articles about COVID-19…

HIGHLIGHTED ARTICLE Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis Devasenapathy N., et al. CMAJ 2020

TOP ARTICLES Blood supply strategies facing a reference blood center in Brazil during the COVID-19 pandemic Maria de Lourdes Barjas-Castro.,  ISBT Science Series 2020 SARS in Canada: Lessons Learned for the Blood Operator Devine Dana V., et al.  Transfusion Medicine 2020 Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study Viecca Maurizio ., et al. Pharmacological Research 2020 Promoting platelets is a therapeutic option to combat severe viral infection of the lung Qiu Jiahuang., et al. Blood Advances 2020 Temporal Changes in Immune Blood Cell Parameters in COVID-19 Infection and Recovery from Severe Infection Yip, C. Y., et al. British Journal of Haematology 2020 Fibrinolysis Shutdown Correlates to Thromboembolic Events in Severe COVID-19 Infection Wright, F. L., et al. Journal of the American College of Surgeons 2020 Anti-Coagulant and Anti-Platelet Therapy in the COVID-19 Patient: A Best Practices Quality Initiative Across a Large Health System Watson, R. A., et al. Hospital Practice 2020 Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum Barnes, G. D., et al. Journal of Thrombosis and Thrombolysis 2020 How did we rapidly implement a convalescent plasma program? Budhai, A., et al. Transfusion 2020